MA27152A1 - Association d'un inhibiteur de pde4 selectif et d'un agoniste de recepteur beta-2 adrenergique - Google Patents
Association d'un inhibiteur de pde4 selectif et d'un agoniste de recepteur beta-2 adrenergiqueInfo
- Publication number
- MA27152A1 MA27152A1 MA27712A MA27712A MA27152A1 MA 27152 A1 MA27152 A1 MA 27152A1 MA 27712 A MA27712 A MA 27712A MA 27712 A MA27712 A MA 27712A MA 27152 A1 MA27152 A1 MA 27152A1
- Authority
- MA
- Morocco
- Prior art keywords
- pde4 inhibitor
- selective pde4
- receptor agonist
- combination
- beta
- Prior art date
Links
- 229940123932 Phosphodiesterase 4 inhibitor Drugs 0.000 title abstract 3
- 239000002587 phosphodiesterase IV inhibitor Substances 0.000 title abstract 3
- 239000000614 adrenergic beta-2 receptor agonist Substances 0.000 title 1
- 229940124627 adrenergic β2 receptor agonist Drugs 0.000 title 1
- 108060003345 Adrenergic Receptor Proteins 0.000 abstract 1
- 102000017910 Adrenergic receptor Human genes 0.000 abstract 1
- 239000000048 adrenergic agonist Substances 0.000 abstract 1
- 229940126157 adrenergic receptor agonist Drugs 0.000 abstract 1
- 239000000556 agonist Substances 0.000 abstract 1
- 102000016966 beta-2 Adrenergic Receptors Human genes 0.000 abstract 1
- 108010014499 beta-2 Adrenergic Receptors Proteins 0.000 abstract 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
- 230000000414 obstructive effect Effects 0.000 abstract 1
- 208000023504 respiratory system disease Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Otolaryngology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
Abstract
DEPOSANT Société dite : PFIZER INC. REVENDICATION DE PRIORITES GB 7 Décembre 2001 0129395.0 Voir en annexe le titre de l'invention et le texte de l'abrégé Association d'un inhibiteur de PDE4 sélectif, et d'un agoniste de récepteur bêta-2 adrénergique La présente invention concerne une association d'un inhibiteur de PDE4 sélectif, tel que défini dans le présent mémoire, et d'un agoniste de récepteur (bêta)2 adrénergique pour une administration simultanée, séquentielle ou séparée par inhalation dans le traitement d'une maladie obstructive des voies aériennes ou d'une autre maladie inflammatoire.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0129395.0A GB0129395D0 (en) | 2001-12-07 | 2001-12-07 | Pharmaceutical combination |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA27152A1 true MA27152A1 (fr) | 2005-01-03 |
Family
ID=9927247
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA27712A MA27152A1 (fr) | 2001-12-07 | 2004-06-02 | Association d'un inhibiteur de pde4 selectif et d'un agoniste de recepteur beta-2 adrenergique |
Country Status (33)
| Country | Link |
|---|---|
| US (2) | US20030119862A1 (fr) |
| EP (1) | EP1455783A1 (fr) |
| JP (1) | JP2005511657A (fr) |
| KR (1) | KR20050044699A (fr) |
| CN (1) | CN1599609A (fr) |
| AP (1) | AP2004003054A0 (fr) |
| AR (1) | AR037712A1 (fr) |
| AU (1) | AU2002353255A1 (fr) |
| BR (1) | BR0214776A (fr) |
| CA (1) | CA2468676A1 (fr) |
| CO (1) | CO5590899A2 (fr) |
| EA (1) | EA200400640A1 (fr) |
| EC (1) | ECSP045142A (fr) |
| GB (1) | GB0129395D0 (fr) |
| HN (1) | HN2002000356A (fr) |
| HR (1) | HRP20040515A2 (fr) |
| HU (1) | HUP0402546A3 (fr) |
| IL (1) | IL162098A0 (fr) |
| IS (1) | IS7277A (fr) |
| MA (1) | MA27152A1 (fr) |
| MX (1) | MXPA04004930A (fr) |
| NO (1) | NO20042870L (fr) |
| NZ (1) | NZ533030A (fr) |
| OA (1) | OA12736A (fr) |
| PA (1) | PA8560601A1 (fr) |
| PE (1) | PE20031066A1 (fr) |
| PL (1) | PL370770A1 (fr) |
| SV (1) | SV2004001430A (fr) |
| TN (1) | TNSN04102A1 (fr) |
| TW (1) | TWI242433B (fr) |
| UY (1) | UY27564A1 (fr) |
| WO (1) | WO2003047578A1 (fr) |
| ZA (1) | ZA200403905B (fr) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030055026A1 (en) | 2001-04-17 | 2003-03-20 | Dey L.P. | Formoterol/steroid bronchodilating compositions and methods of use thereof |
| TWI359675B (en) * | 2003-07-10 | 2012-03-11 | Dey L P | Bronchodilating β-agonist compositions |
| DE10360954B3 (de) * | 2003-12-23 | 2005-08-18 | Esparma Gmbh | Verwendung von Silibinin, dessen Salzen und/oder dessen Prodrugs zusammen mit α-Liponsäure zur Behandlung chronisch obstruktiver Lungenerkrankungen |
| WO2012098495A1 (fr) * | 2011-01-19 | 2012-07-26 | Glenmark Pharmaceuticals Sa | Composition pharmaceutique qui comprend le revamilast et un agoniste de bêta-2 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX9709897A (es) * | 1995-06-06 | 1998-03-31 | Pfizer | 5-6-dihidro-9h-pirazol[3,4-c]-1,2,4-triazol[4,3-a]piridinas triciclicas y el uso de las mismas. |
| CA2341488A1 (fr) * | 1998-08-26 | 2000-03-09 | Smithkline Beecham Corporation | Compositions pour le traitement de maladies pulmonaires |
| PL200923B1 (pl) * | 1999-08-21 | 2009-02-27 | Nycomed Gmbh | Lek zawierający inhibitor PDE w połączeniu z agonistą receptoraß₂ -adrenergicznego oraz zastosowanie połączenia roflumilastu i salmeterolu |
-
2001
- 2001-12-07 GB GBGB0129395.0A patent/GB0129395D0/en not_active Ceased
-
2002
- 2002-11-22 CA CA002468676A patent/CA2468676A1/fr not_active Abandoned
- 2002-11-22 BR BR0214776-9A patent/BR0214776A/pt not_active IP Right Cessation
- 2002-11-22 OA OA1200400162A patent/OA12736A/en unknown
- 2002-11-22 PL PL02370770A patent/PL370770A1/xx not_active Application Discontinuation
- 2002-11-22 KR KR1020047008613A patent/KR20050044699A/ko not_active Abandoned
- 2002-11-22 JP JP2003548833A patent/JP2005511657A/ja not_active Withdrawn
- 2002-11-22 EP EP02788275A patent/EP1455783A1/fr not_active Withdrawn
- 2002-11-22 EA EA200400640A patent/EA200400640A1/ru unknown
- 2002-11-22 WO PCT/IB2002/004922 patent/WO2003047578A1/fr not_active Ceased
- 2002-11-22 MX MXPA04004930A patent/MXPA04004930A/es unknown
- 2002-11-22 AP APAP/P/2004/003054A patent/AP2004003054A0/en unknown
- 2002-11-22 CN CNA028243935A patent/CN1599609A/zh active Pending
- 2002-11-22 HR HR20040515A patent/HRP20040515A2/hr not_active Application Discontinuation
- 2002-11-22 AU AU2002353255A patent/AU2002353255A1/en not_active Abandoned
- 2002-11-22 HU HU0402546A patent/HUP0402546A3/hu unknown
- 2002-11-22 IL IL16209802A patent/IL162098A0/xx unknown
- 2002-11-22 NZ NZ533030A patent/NZ533030A/en not_active IP Right Cessation
- 2002-12-03 US US10/308,962 patent/US20030119862A1/en not_active Abandoned
- 2002-12-05 AR ARP020104719A patent/AR037712A1/es unknown
- 2002-12-05 UY UY27564A patent/UY27564A1/es not_active Application Discontinuation
- 2002-12-05 PE PE2002001175A patent/PE20031066A1/es not_active Application Discontinuation
- 2002-12-05 HN HN2002000356A patent/HN2002000356A/es unknown
- 2002-12-06 SV SV2002001430A patent/SV2004001430A/es not_active Application Discontinuation
- 2002-12-06 TW TW091135479A patent/TWI242433B/zh not_active IP Right Cessation
- 2002-12-06 PA PA20028560601A patent/PA8560601A1/es unknown
-
2003
- 2003-12-16 US US10/736,996 patent/US20040167153A1/en not_active Abandoned
-
2004
- 2004-05-20 ZA ZA200403905A patent/ZA200403905B/en unknown
- 2004-05-21 IS IS7277A patent/IS7277A/is unknown
- 2004-06-02 MA MA27712A patent/MA27152A1/fr unknown
- 2004-06-04 CO CO04052217A patent/CO5590899A2/es not_active Application Discontinuation
- 2004-06-04 TN TNP2004000102A patent/TNSN04102A1/fr unknown
- 2004-06-07 EC EC2004005142A patent/ECSP045142A/es unknown
- 2004-07-06 NO NO20042870A patent/NO20042870L/no not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Langley et al. | Nimodipine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cerebrovascular disease | |
| MA26955A1 (fr) | INHIBITEURS DES RECEPTEURS EP4 POUR LE TRAITEMENT DE L'ARTHRITE RHUMATOiDE | |
| TNSN01053A1 (fr) | Compositions nouvelles comprenant un agoniste partiel des recepteurs de nicotine et un agent analgesique | |
| MA28303A1 (fr) | Derives de sulfonamides pour le traitement de maladies | |
| TNSN07063A1 (fr) | Utilisations therapeutiques d'inhibiteurs de rtp801 | |
| EP1370211A4 (fr) | Co-administration de l'agoniste du recepteur de la melanocortine et inhibiteur de phosphodiesterase pour le traitement de troubles associes a l'amp cyclique | |
| SG127739A1 (en) | Use of immuno-regulators | |
| MA27060A1 (fr) | Therapeutique mixte pour le traitement du cancer | |
| MA25809A1 (fr) | Derives d'arylmethylamine pour usage comme inhibiteurs de tryptase | |
| EA200000299A1 (ru) | Лекарства | |
| MA28284A1 (fr) | Nitro-oxydérivés de prostaglandines | |
| TNSN07021A1 (fr) | Derives de quinazoline -4-yl-piperidine et cinnoline -4-yl-piperidine servant d'inhibiteurs de pde10 pour le traitement de troubles du snc | |
| EP1551369A4 (fr) | Therapie de combinaison pour le traitement de troubles fibrosants | |
| MA26874A1 (fr) | Arylpyrazines substituées | |
| MXPA03008955A (es) | Agente terapeutico para enfermedades de tipo artritides cronicas o enfermedades relacionadas con la ninez. | |
| MA27451A1 (fr) | Derives de thiazole pour le traitement de troubles neurodegeneratifs | |
| ATE304533T1 (de) | Tetrahydrochinolinderivate als muscarinische agonisten | |
| MA27840A1 (fr) | Derives de (2-hydroxy-2-(4-hydroxy-3-hydroxymethylphenyl)-ethylamino)-propylphenyle servant d'agonistes beta2 | |
| MA30901B1 (fr) | Therapie de combinaison sequentielle | |
| MA29723B1 (fr) | Composes | |
| TW200531680A (en) | Therapy using 1-aminocyclohexane derivatives for the treatment of behavioral disorders associated with alzheimer's disease | |
| MXPA05009986A (es) | Tratamiento de la enfermedad de alzheimer. | |
| MA26953A1 (fr) | Derives de pipérazine pontés. | |
| MY135916A (en) | Use of certain affinity nmda antagonists as antidepressants | |
| IS4722A (is) | Notkun 1-(2-naft-2-ýletýl)-4(3-tríflúorómetýlfenýl)-1,2,3,6-tetrahýdrópýridíns til gerðar lyfja tilþess að meðhöndla hliðarstrengjahersli |